These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18218578)

  • 1. Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan.
    Chu PC; Hwang JS; Wang JD; Chang YY
    J Formos Med Assoc; 2008 Jan; 107(1):54-63. PubMed ID: 18218578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan.
    Chung CW; Wang JD; Yu CF; Yang MC
    Tob Control; 2007 Dec; 16(6):394-9. PubMed ID: 18048616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance.
    Yip WC; Lee YC; Tsai SL; Chen B
    Soc Sci Med; 2019 Jul; 233():272-280. PubMed ID: 29548564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples.
    Lee LJ; Chang YY; Liou SH; Wang JD
    Occup Environ Med; 2012 Aug; 69(8):582-6. PubMed ID: 22576592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
    Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of cancer treatment in Taiwan.
    Hung MC; Lai WW; Chen HH; Lee JC; Lin YJ; Hsiao JR; Cheng YM; Shan YS; Su WC; Wang JD
    J Formos Med Assoc; 2016 Aug; 115(8):609-18. PubMed ID: 27302557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of work-related cancers in Taiwan-Estimation with QALY (quality-adjusted life year) and healthcare costs.
    Lee LJ; Lin CK; Hung MC; Wang JD
    Prev Med Rep; 2016 Dec; 4():87-93. PubMed ID: 27413666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization patterns and risk adjustment under Taiwan's National Health Insurance system.
    Chang RE; Lin W; Hsieh CJ; Chiang TL
    J Formos Med Assoc; 2002 Jan; 101(1):52-9. PubMed ID: 11911039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of diabetes pay-for-performance incentive designs.
    Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
    Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the persistence of health expenditures and the implications for the design of capitation payments in Taiwan.
    Ku LJ; Chiou MJ; Liu LF
    J Health Serv Res Policy; 2015 Jul; 20(3):146-53. PubMed ID: 25829410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life.
    Liu CN; Yang MC
    J Formos Med Assoc; 2002 Aug; 101(8):552-9. PubMed ID: 12440085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived Impact of Taiwan's National Health Insurance Allocation Strategy: Health Professionals' Perspective.
    Owili PO; Muga MA; Yang YT; Hsu YE
    Int J Environ Res Public Health; 2019 Feb; 16(3):. PubMed ID: 30764553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of diagnosis-based risk adjustment models to predict individual health care expenditure under the National Health Insurance system in Taiwan.
    Chang RE; Lai CL
    J Formos Med Assoc; 2005 Dec; 104(12):883-90. PubMed ID: 16607444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
    Lang HC; Wu JC; Yen SH; Lan CF; Wu SL
    Appl Health Econ Health Policy; 2008; 6(1):55-65. PubMed ID: 18774870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years.
    Ou HT; Yang CY; Wang JD; Hwang JS; Wu JS
    Value Health; 2016 Dec; 19(8):976-984. PubMed ID: 27987648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial perfusion scintigraphy in Taiwan from 2005 to 2009.
    Hung MC; Chang PW; Hsieh WA; Hwang JJ
    Nucl Med Commun; 2012 Jul; 33(7):733-8. PubMed ID: 22395035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.
    Hung MC; Lai WW; Chen HH; Su WC; Wang JD
    Cancer Epidemiol; 2015 Feb; 39(1):126-32. PubMed ID: 25553846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient drug expenditures and prescription policies for diseases with high cost to the National Health Insurance system in Taiwan.
    Lang HC; Lai MS; Chen GT
    J Formos Med Assoc; 2004 Apr; 103(4):280-5. PubMed ID: 15175823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan.
    Wu TY; Chung CH; Lin CN; Hwang JS; Wang JD
    Clin Epidemiol; 2018; 10():581-591. PubMed ID: 29872347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spillover effect of National Health Insurance on household consumption patterns: evidence from a natural experiment in Taiwan.
    Sheu JT; Lu JF
    Soc Sci Med; 2014 Jun; 111():41-9. PubMed ID: 24747377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.